small intestinal neuroendocrine tumor G1
disease diseaseOn this page
Also known as carcinoid tumor of small bowelcarcinoid tumor of small intestinecarcinoid tumor of the small bowelcarcinoid tumor of the small intestinecarcinoid tumour of small bowelcarcinoid tumour of small intestinecarcinoid tumour of the small bowelcarcinoid tumour of the small intestinegrade 1 neuroendocrine neoplasm of small intestinesmall bowel carcinoid tumorsmall bowel carcinoid tumoursmall intestinal carcinoid tumorsmall intestinal carcinoid tumoursmall intestinal NET G1small intestine carcinoid neuroendocrine tumoursmall intestine carcinoid tumorsmall intestine carcinoid tumor (disease)small intestine carcinoid tumoursmall intestine carcinoid tumour (disease)
Summary
small intestinal neuroendocrine tumor G1 (MONDO:0000540) is a cancer and 5 clinical trials. A subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 5
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | small intestinal neuroendocrine tumor G1 |
| Mondo ID | MONDO:0000540 |
| DOID | DOID:0050925 |
| NCIT | C4638 |
| SNOMED CT | 276818002 |
| UMLS | C0349536 |
| MedGen | 91150 |
| GARD | 0022796 |
| Anatomy (UBERON) | UBERON:0002108 |
| Is cancer (heuristic) | yes |
Also known as: carcinoid tumor of small bowel · carcinoid tumor of small intestine · carcinoid tumor of the small bowel · carcinoid tumor of the small intestine · carcinoid tumour of small bowel · carcinoid tumour of small intestine · carcinoid tumour of the small bowel · carcinoid tumour of the small intestine · grade 1 neuroendocrine neoplasm of small intestine · small bowel carcinoid tumor · small bowel carcinoid tumour · small intestinal carcinoid tumor · small intestinal carcinoid tumour · small intestinal NET G1 · small intestinal neuroendocrine tumor G1 · small intestine carcinoid neuroendocrine tumour · small intestine carcinoid tumor · small intestine carcinoid tumor (disease) · small intestine carcinoid tumour · small intestine carcinoid tumour (disease) (+3 more)
Disease family
This is a subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system neuroendocrine neoplasm › digestive system neuroendocrine tumor, grade 1/2 › small intestine neuroendocrine tumor, well differentiated, low or intermediate grade › small intestinal neuroendocrine tumor G1
Related subtypes (5): small intestinal vasoactive intestinal peptide producing tumor, small intestinal L-cell glucagon-like peptide producing tumor, duodenal neuroendocrine tumor, well differentiated, low or intermediate grade, jejunal neuroendocrine tumor, well differentiated, low or intermediate grade, ileal neuroendocrine tumor, well differentiated, low or intermediate grade
Subtypes (2): ileal neuroendocrine tumor G1, jejunal neuroendocrine tumor G1
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 5.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 3 |
| PHASE3 | 1 |
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01578239 | PHASE3 | COMPLETED | A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours |
| NCT03057509 | PHASE1 | WITHDRAWN | A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors |
| NCT04907643 | Not specified | RECRUITING | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
| NCT03622333 | Not specified | UNKNOWN | Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d’étude Des Tumeurs Endocrines) |
| NCT05670574 | Not specified | UNKNOWN | Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.